COMORAL® the Oral Irrigation Unit Clinical Trial
COMORAL
Effect of COMORAL® the Oral Irrigation Unit in Preventing Gingivitis and Plaque Formation
1 other identifier
interventional
42
0 countries
N/A
Brief Summary
This is a clinical study to evaluate the safety and effectiveness of COMORAL®, the intraoral water-spraying cleaning device that is developed to remove plaque around teeth in the oral cavity. To do so, 42 healthy subjects, 21 control and 21 experimental, will be recruited. To establish the baseline, all subjects will receive dental hygiene service. After 2 weeks, patients will be randomly assigned to either control or intervention group (21 individuals each). Both groups will be asked to brush their teeth once a day but without dental floss, mouth rinse, and gum chewing, throughout the 4 weeks of study period. During the study period, the experimental group will receive COMORAL® treatment three times a day every day for 4 weeks except Saturday and Sunday. Subjects will get evaluated for the oral status(PI, BOP, GI, PD, GR, CAL) and the status of periopathogens on visit 1, visit 2 and visit 3.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2021
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 20, 2021
CompletedFirst Posted
Study publicly available on registry
September 1, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedSeptember 1, 2021
August 1, 2021
2 months
July 20, 2021
August 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
gingival index (GI)
the scoring system for mild inflammation(modified gingival index)
Baseline, 2 weeks, 4 weeks
plaque index (PI)
the amount of dental plaque visible on the vestibular and lingual surfaces
Baseline, 2 weeks, 4 weeks
bleeding on probing (BOP)
the scoring system recorded 20 seconds after probing the depth of the pocket
Baseline, 2 weeks, 4 weeks
pocket depth (PD)
the distance from the gingival margin to pocket base
Baseline, 2 weeks, 4 weeks
gingival recession (GR)
the distance of the displacement of marginal gingiva apical to the cemento-enamel junction
Baseline, 2 weeks, 4 weeks
clinical attachment loss (CAL)
the distance between the cementoenamel junction and the base of the probeable pocket
Baseline, 2 weeks, 4 weeks
Secondary Outcomes (1)
Periopathogens (PP)
Baseline, 2 weeks, 4 weeks
Study Arms (2)
Control group
NO INTERVENTIONThe individuals in the control group will be asked to brush their teeth (2x per day) at home throughout the 4 weeks of study period. They will be asked not to use the supplementary oral hygiene products including mouth rinse, dental floss and chewing gum.
Experimental group
EXPERIMENTALThe individuals in this group will be asked to brush their teeth (2x per day) at home throughout the 4 weeks of study period. They will be asked not to use the supplementary oral hygiene products including mouth rinse, dental floss and chewing gum. Instead, they will be asked to come to the clinic to use COMORAL® three times a day, every day except Saturday and Sunday.
Interventions
The individuals in the experimental group will be asked to come to the clinic to use COMORAL® three times a day, every day except Saturday and Sunday.
Eligibility Criteria
You may qualify if:
- Healthy adult patients (ASA 1-2) aged 18 to 25 with a probing depth of 3mm or less
- Those with 3 or more natural teeth in each quartile
- Those who can voluntarily sign the consent form
You may not qualify if:
- Existing dental caries
- Existing periodontitis
- Other oral diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Reuben Kim, DDS, PhD
University of California, Los Angeles
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chair
Study Record Dates
First Submitted
July 20, 2021
First Posted
September 1, 2021
Study Start
October 1, 2021
Primary Completion
November 30, 2021
Study Completion
June 30, 2022
Last Updated
September 1, 2021
Record last verified: 2021-08